Lifestyle associated reactive metabolites and their negative impact on breast cancer risk

生活方式相关的反应性代谢物及其对乳腺癌风险的负面影响

基本信息

  • 批准号:
    10206074
  • 负责人:
  • 金额:
    $ 41.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-01 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT The focus of this study is on early life factors and their effect on mammary development during puberty and how they relate to increased breast cancer risk. At this time we do not understand what biological changes occur during pubertal mammary development which leads to a greater risk of developing cancer in later life. Identifying the molecular mechanisms that cause aberrant pubertal mammary development may lead to defined strategies to reduce breast cancer burden in later life. As our bodies use the sugars that we consume for energy they generate waste chemicals known as metabolites. One such group of metabolites is known as advanced glycation end products or AGEs for short. Critically apart from their production as a result of the breakdown of sugar, AGE’s are also formed through the ingestion of food and by external environmental factors such as lack of exercise. Changes in this dynamic equilibrium causes protein dysfunction, protein crosslinking, decreased genetic fidelity, altered gene expression profiles and aberrant cell signaling. Our studies have identified in animal models that a diet high in AGEs significantly alters how the breast develops during puberty. The tumor microenvironment is now becoming recognized as having a major role in facilitating both mammary development and cancer progression, and that, alterations in stromal cell signaling can precede epithelial cell alterations and act as drivers of the tumorigenic process. Critically, the high AGE diet produces architecture in the breast that resembles pre-neoplastic lesions with hyper-proliferative structures and increased levels of stromal cells. We also show that AGE levels are significantly elevated in the circulation and tumor tissue of breast cancer patients and that AGE treatment alters cancer associated signaling pathways to promote breast tumor growth. This study aims to define the mechanism by which a high-AGE diet causes the dysregulation of the mammary gland during puberty (SA1) and adulthood (SA2) and will ask if the changes observed lead to a higher risk of breast tumor formation and growth (SA3). A greater mechanistic understanding of the link between AGE intake during puberty and increased breast cancer risk may define novel potential strategies for lifestyle and pharmacological intervention aimed at reducing breast cancer risk at a defined window of susceptibility.
项目概要/摘要 本研究的重点是早期生活因素及其对青春期和乳腺发育的影响。 它们与乳腺癌风险增加有何关系 目前我们还不了解哪些生物学变化。 发生在青春期乳房发育期间,导致晚年患癌症的风险更大。 确定导致青春期乳腺发育异常的分子机制可能会导致 制定了减少晚年乳腺癌负担的策略。 当我们的身体使用我们消耗的糖作为能量时,它们会产生废弃的化学物质,称为 其中一组代谢物被称为晚期糖基化终产物,简称 AGE。 重要的是,除了糖分解产生的 AGE 之外,AGE 还通过 食物的摄入和缺乏运动等外部环境因素会导致这种动态变化。 平衡导致蛋白质功能障碍、蛋白质交联、遗传保真度降低、基因 表达谱和异常细胞信号传导。 我们的研究在动物模型中发现,高 AGE 饮食会显着改变乳房的发育方式。 现在人们认识到肿瘤微环境在青春期发展中发挥着重要作用。 促进乳腺发育和癌症进展,并且基质细胞信号传导的改变 可以先于上皮细胞改变并作为致瘤过程的驱动因素,关键是高 AGE。 饮食产生的乳房结构类似于具有过度增殖结构的肿瘤前病变 我们还发现循环中的 AGE 水平显着升高。 和乳腺癌患者的肿瘤组织,AGE 治疗改变癌症相关信号传导 促进乳腺肿瘤生长的途径。 本研究旨在明确高 AGE 饮食导致乳腺失调的机制 青春期 (SA1) 和成年期 (SA2) 期间的腺体,并会询问观察到的变化是否会导致更高的风险 乳腺肿瘤的形成和生长(SA3)。 更深入地了解青春期 AGE 摄入量与乳房增大之间的联系 癌症风险可能会为生活方式和药物干预定义新的潜在策略 在确定的易感性窗口内降低乳腺癌风险。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEVEN M ANDERSON其他文献

STEVEN M ANDERSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEVEN M ANDERSON', 18)}}的其他基金

TISSUE CULTURE/ MAb CORE
组织培养/单克隆抗体核心
  • 批准号:
    8616657
  • 财政年份:
    2014
  • 资助金额:
    $ 41.14万
  • 项目类别:
Endocrine Network for Undergraduate Research and Carrier Development Opportunitie
本科生研究和载体发展机会内分泌网络
  • 批准号:
    8233329
  • 财政年份:
    2011
  • 资助金额:
    $ 41.14万
  • 项目类别:
Endocrine Network for Undergraduate Research and Carrier Development Opportunitie
本科生研究和载体发展机会内分泌网络
  • 批准号:
    8013376
  • 财政年份:
    2011
  • 资助金额:
    $ 41.14万
  • 项目类别:
Endocrine Network for Undergraduate Research and Carrier Development Opportunitie
本科生研究和载体发展机会内分泌网络
  • 批准号:
    8460849
  • 财政年份:
    2011
  • 资助金额:
    $ 41.14万
  • 项目类别:
Is GLUT1 required for tumor growth and the Warburg Effect?
肿瘤生长和瓦尔堡效应需要 GLUT1 吗?
  • 批准号:
    8505396
  • 财政年份:
    2011
  • 资助金额:
    $ 41.14万
  • 项目类别:
Is GLUT1 required for tumor growth and the Warburg Effect?
肿瘤生长和瓦尔堡效应需要 GLUT1 吗?
  • 批准号:
    8333385
  • 财政年份:
    2011
  • 资助金额:
    $ 41.14万
  • 项目类别:
Endocrine Network for Undergraduate Research and Carrier Development Opportunitie
本科生研究和载体发展机会内分泌网络
  • 批准号:
    8626413
  • 财政年份:
    2011
  • 资助金额:
    $ 41.14万
  • 项目类别:
Is GLUT1 required for tumor growth and the Warburg Effect?
肿瘤生长和瓦尔堡效应需要 GLUT1 吗?
  • 批准号:
    8188853
  • 财政年份:
    2011
  • 资助金额:
    $ 41.14万
  • 项目类别:
Endocrine Network for Undergraduate Research and Carrier Development Opportunitie
本科生研究和载体发展机会内分泌网络
  • 批准号:
    8821630
  • 财政年份:
    2011
  • 资助金额:
    $ 41.14万
  • 项目类别:
Functional Development of the Mammary Gland
乳腺的功能发育
  • 批准号:
    8062791
  • 财政年份:
    2010
  • 资助金额:
    $ 41.14万
  • 项目类别:

相似海外基金

An enzyme-based assay for the detection of acetaldehyde-protein adducts
用于检测乙醛-蛋白质加合物的酶测定法
  • 批准号:
    10760201
  • 财政年份:
    2023
  • 资助金额:
    $ 41.14万
  • 项目类别:
Lifestyle associated reactive metabolites and their negative impact on breast cancer risk
生活方式相关的反应性代谢物及其对乳腺癌风险的负面影响
  • 批准号:
    10625616
  • 财政年份:
    2022
  • 资助金额:
    $ 41.14万
  • 项目类别:
Lifestyle associated reactive metabolites and their negative impact on breast cancer risk
生活方式相关的反应性代谢物及其对乳腺癌风险的负面影响
  • 批准号:
    10442513
  • 财政年份:
    2022
  • 资助金额:
    $ 41.14万
  • 项目类别:
Advanced glycation end products and colorectal cancer risk in women
女性晚期糖基化终产物和结直肠癌风险
  • 批准号:
    8049935
  • 财政年份:
    2011
  • 资助金额:
    $ 41.14万
  • 项目类别:
Advanced glycation end products and colorectal cancer risk in women
女性晚期糖基化终产物和结直肠癌风险
  • 批准号:
    8327103
  • 财政年份:
    2011
  • 资助金额:
    $ 41.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了